Minimally Invasive Glaucoma Surgery (MIGS) · Patient Information Brochure
Glaucoma (Kala Motia) is a group of eye diseases where raised intraocular pressure (IOP) silently damages the optic nerve — the cable that carries images from the eye to the brain.
Because peripheral vision is lost first, most patients notice nothing until 40–50% of nerve fibres are already destroyed. Lost vision cannot be restored — only future loss can be prevented.
Maps the full field of vision. Glaucoma causes arcuate scotomas — crescent-shaped blind spots. Repeated tests track progression.
Measures retinal nerve fibre layer in microns. Detects glaucoma before visual field loss (up to 5 years earlier). Inferior thinning is the earliest sign.
Measures corneal thickness. Thin corneas (<510 µm) give falsely low IOP readings — a hidden risk factor for glaucoma damage despite "normal" pressure.
Source: HORIZON Randomised Controlled Trial · Courtesy: alcon.com
The Hydrus Microstent is an 8 mm nitinol (nickel-titanium) scaffold — thinner than a human hair — placed inside Schlemm's canal through the same tiny incision used for cataract surgery.
| Treatment | How it Works | IOP Reduction | Key Concern |
|---|---|---|---|
| Eye Drops | Reduce aqueous production / increase outflow | 20–30% | Compliance, side-effects, lifelong cost |
| SLT Laser | Opens trabecular meshwork | 25–30% | Effect wears off in 3–5 yrs; repeatable |
| Trabeculectomy | Creates external drainage bleb | 40–50% | Bleb infection (blebitis), hypotony, frequent visits |
| iStent inject | 2 small trabecular bypass stents | 25–35% | Smaller scaffold, less canal coverage |
| XEN Gel Stent | Sub-conjunctival micro-tube | 35–45% | External bleb, needling often needed |
| Hydrus ✓ | 8 mm canal scaffold — widest drainage | 77% at 2 yrs | Safest MIGS profile; no external bleb |